FDA Approved: BENZTROPINE MESYLATE — Original Application (SUNRISE PHARMACEUTICAL, INC)

View source ↗

Summary

FDA approved an original ANDA for Benztropine Mesylate by Sunrise Pharmaceutical, expanding generic options for Parkinsonism and extrapyramidal symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Extrapyramidal Disorders
• Extrapyramidal Symptoms
• Parkinson Disease

Drugs mentioned

• Benztropine Mesylate (benztropine mesylate)

Snippet

ORIG AP for BENZTROPINE MESYLATE (BENZTROPINE MESYLATE)